ÂÜÀòÂÒÂ×

V. Lyle King, Ph.D., currently serves as a Senior Associate at Cure Ventures and has been involved with Cure Ventures Stealth NewCo as a Program Lead and Board Observer since August 2023. Prior experience includes roles as a Teaching Assistant and Graduate Student Researcher at the University of Connecticut from August 2016 to July 2022, and as an Undergraduate Research Assistant at the University of Mary Washington from August 2012 to May 2016, along with an internship at Intrexon Corporation in the UltraVector Division in the summer of 2015. V. Lyle King earned a Doctor of Philosophy in Molecular and Cell Biology from the University of Connecticut and a Bachelor’s Degree in Biological Sciences from the University of Mary Washington.